Longevity, Performance & Obesity Research (60 Capsules)

Peptide Science research editorial team.

Longevity and Obesity Research 60-Capsule Blend Overview

Longevity and Obesity Research 60-Capsule Blend from Peptide Science is a three-active capsule formulation supplying 5-Amino-1MQ at 50 mg, beta-Nicotinamide Mononucleotide (NMN) at 50 mg, and JBSNF-000088 at 5 mg per capsule, sealed in a 60-count bottle for preclinical bioenergetics and adipose-research applications. The capsule format is preferred for animal-model studies requiring oral-bioavailability protocols, where the gelatin shell stabilises the three actives during gastric transit.

Mechanism in NAD+ and NNMT Research

The three actives target adjacent nodes of the nicotinamide / NAD+ axis. 5-Amino-1MQ (5-Amino-1-methylquinolinium) is a small-molecule inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT); inhibiting NNMT preserves intracellular nicotinamide for conversion to NAD+. NMN is a direct biosynthetic precursor to NAD+, entering the salvage pathway via the NMNAT enzyme family. JBSNF-000088 is a separate NNMT inhibitor characterised in preclinical animal-model work for downstream effects on insulin sensitivity and adipose-tissue mass. Together the three compounds act at three different points on the same metabolic axis, supporting comparison-pathway studies in adipocyte cell-culture and high-fat-diet animal models. Browse related material in the metabolic peptide research catalogue.

Per-Capsule Specifications

Handling and Stability

The sealed capsule bottle stores at room temperature in a dry environment, away from direct sunlight and humidity, with the desiccant pouch retained in the cap. For comparison studies that pair NNMT-pathway research with pineal-tetrapeptide telomerase work, see Epithalon (Epitalon) 20mg.

Quality and Shipping

Each active passes HPLC at greater than 99 percent purity. A signed Certificate of Analysis ships with every order, listing the three actives individually with their per-capsule mass. Material is prepared in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in standard sealed packaging via overnight or two-day courier. For paired research with the GLP-1 receptor agonist class, see the wider weight-loss and metabolic peptide range.

For laboratory research and development use only. Not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease, including obesity or type 2 diabetes. Has not been evaluated by the U.S. Food and Drug Administration. Branded therapeutic GLP-1 and GIP medicines (Ozempic, Wegovy, Mounjaro, Zepbound) are prescription-only medicines in the United States and are not the same as research-grade compounds supplied for in-vitro work. Purchasers acknowledge they are qualified researchers age 21 or older and accept responsibility for compliance with all applicable federal, state, and local laws.